Show simple item record

dc.contributor.authorMacleod, S
dc.contributor.authorSewell, GJ
dc.date.accessioned2015-11-18T16:43:05Z
dc.date.available2015-11-18T16:43:05Z
dc.date.issued2011
dc.identifier.urihttp://hdl.handle.net/10026.1/3814
dc.description.abstract

Study objectives: To investigate the long-term physical and chemical stability of 0.3 mg/mL and 0.7 mg/mL infusions of docetaxel (Teva) in polyolefin bags containing either 0.9% sodium chloride or 5% glucose, stored under refrigerated (2°C–8°C) and room temperature (25°C) conditions protected from the light. Methods: The infusions were prepared aseptically and stored at the two temperatures for 56 days. At various time points, chemical stability was determined using a validated stability-indicating, high performance liquid chromatography (HPLC) assay. Physical stability was ascertained in terms of visual appearance, pH, weight change of infusions, and sub-visible particles counts. Results: Irrespective of drug concentration, diluent type, or storage temperature, docetaxel infusions were compliant with both physical and chemical acceptance criteria over the 56-day study period. Conclusion: This study has demonstrated the extended stability of docetaxel (Teva) infusions over the concentration range 0.3–0.7 mg/mL in polyolefin bags containing either 0.9% sodium chloride or 5% glucose and stored at either 2°C–8°C or 25°C. These findings will enable pre-preparation and storage of these infusions by Centralised Intravenous Additive Services (CIVAS) units and the application of dose-banding schemes. As with all infusions where physical stability is potentially limited, docetaxel infusions should be carefully inspected for precipitation both before and during use irrespective of the storage period before use.

dc.language.isoen
dc.titlePhysical and chemical stability of docetaxel infusions in polyolefin bags containing 0.9% soduim chloride or 5% glucose at 5 ͦC and 25 ͦC
dc.typejournal-article
dc.typeArticle
plymouth.edition2011/12
plymouth.volume17
plymouth.journalEuropean Journal of Hospital Pharmacy
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Health Professions
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy MANUAL
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Users by role
dcterms.dateAccepted2011-01-01
dc.rights.embargoperiodNot known
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV